Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways by Shuying Dong et al.
Dong et al. Journal of Translational Medicine 2013, 11:273
http://www.translational-medicine.com/content/11/1/273RESEARCH Open AccessInsufficient radiofrequency ablation promotes
epithelial-mesenchymal transition of
hepatocellular carcinoma cells through Akt and
ERK signaling pathways
Shuying Dong1†, Jian Kong1†, Fandong Kong1†, Jinge Kong3, Jun Gao1, Shan Ke1, Shaohong Wang1, Xuemei Ding1,
Wenbing Sun1* and Lemin Zheng2*Abstract
Background: Residual tumor progression after insufficient radiofrequency ablation (RFA) has been recently
reported. However, whether epithelial-mesenchymal transition (EMT), which is a key process that drives cancer
metastasis, is involved in the tumor progression after insufficient RFA is not well understood.
Methods: Human hepatocellular carcinoma (HCC) cell lines SMMC7721 and Huh7 were used. Insufficient RFA was
simulated using a water bath (47°C 5 min, 10 min, 15 min, 20 min and 25 min gradually). MTT assay was used to
evaluate the proliferation of HCC cells in vitro. Migration and invasion of HCC cells were determined by transwell
assay. The molecular changes in HCC cells after insufficient RFA were evaluated by western blot. LY294002 and
PD98059 were used to treat HCC cells. An ectopic nude mice model and a tail vein metastatic assay were used to
evaluate the growth and metastatic potential of SMMC7721 cells in vivo after insufficient RFA.
Results: SMMC7721 and Huh7 cells after insufficient RFA (named as SMMC7721-H and Huh7-H respectively)
exhibited enhanced proliferation, migration and invasion (6.4% and 23.6%, 33.2% and 66.1%, and 44.1% and 57.4%
increase respectively) in vitro. Molecular changes of EMT were observed in SMMC7721-H and Huh7-H cells.
LY294002 and PD98059 inhibited the EMT of SMMC7721-H and Huh7-H cells. SMMC7721-H cells also exhibited
larger tumor size (1440.8 ± 250.3 mm3 versus 1048.56 ± 227.6 mm3) and more lung metastasis (97.4% increase) than
SMMC7721 cells in vivo. Higher expression of PCNA, N-cadherin and MMP-2 and MMP-9, was also observed in
SMMC7721-H tumors.
Conclusions: Insufficient RFA could directly promote the invasiveness and metastasis of HCC cells. Insufficient RFA
may promote the EMT of HCC cells through Akt and ERK signaling pathways.
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Hepatocellular carcinoma (HCC) is the fifth most
common cancer in men and the seventh in women
worldwide [1]. Radiofrequency ablation (RFA) is one of
the treatments for HCC and is now widely used for
curative strategies [2]. However, for the RFA procedure
to be considered technically successful, the tumor and a
safety margin of at least 5 mm of normal hepatic tissue
must be completely included in the ablation zone [3],
therefore the major problem with RFA is its difficulty in
achieving complete tumor destruction [4].
Residual tumor progression after insufficient RFA has
been recently reported and two possible mechanisms also
have been proposed. RFA may alter tumor microenviron-
ment to enhance the outgrowth of residual tumor cells.
RFA could accelerate perinecrotic outgrowth of colorectal
liver metastases in a hypoxia-dependent manner [4,5]. An-
other study showed that thermal ablation promoted the
progression of micrometastases to form macroscopically
detectable neoplasms in treated regenerating liver through
an increased expression of vascular endothelial growth
factor (VEGF) and fibroblast growth factor-2 (FGF-2)
adjacent to the treatment site [6]. Our previous study also
showed that tumor-associated endothelial cells after
insufficient RFA exhibited enhanced angiogenesis and
promoted invasiveness of residual HCC [7]. Alternatively,
RFA could directly influence tumor cells to promote
progression of residual tumor. Our previous studies dem-
onstrated that HCC cells after insufficient RFA induced
angiogenesis via hypoxia inducer factor (HIF-1) α/ VEGFA
in vitro [8], and insufficient RFA could facilitate the
growth and metastasis of residual hepatic VX2 carcinoma
owing to the induction of over-expression of PCNA,
VEGF and MMP-9 [9]. Another study also indicated that
insufficient RFA may induce further malignant transform-
ation of HCC [10]. However, rapid progression of residual
tumor after insufficient RFA is a complex process and
further mechanisms need to be elucidated. Metastases,
termed the invasion-metastasis cascade, involve dissemin-
ation of cancer cells to anatomically distant organ sites
and their subsequent adaptation to foreign tissue microen-
vironments [11], which 90% of mortality from cancer is
attributable to [12]. Whether insufficient RFA could
directly promote invasion-metastasis of residual HCC cells
and the mechanisms involved in the process have not
been clearly determined.
Epithelial-mesenchymal transition (EMT) is a key
process that drives cancer metastasis, and it is character-
ized by loss of the epithelial marker, increased expression
of the mesenchymal marker, and enhanced migratory and
invasive behaviors [13,14]. Characteristic down-regulation
of E-cadherin is regarded as the key step to EMT. HCCs
with EMT features consistently exhibit more venous
invasion, metastases, and a poorer prognosis than thosewithout EMT characteristics [15]. Whether insufficient
RFA directly induces the EMT of residual HCC cells and
further promotes the metastasis remains unclear.
In the present study, we investigated the morpho-
logical changes, cell growth, migration and invasion of
HCC cell lines (SMMC7721 and Huh7) after insufficient
RFA in vitro. Furthermore, we analyzed the changes of
epithelial and mesenchymal markers, and Akt and
ERK1/2 signaling pathways involved in the process in
HCC cells after insufficient RFA. We also performed
in vivo experiments to study the growth and metastasis




Established human HCC cell lines, SMMC7721 and
Huh7 were from the American Type Culture Collection
(ATCC; Manassas, VA, USA). All cells were maintained
in high-glucose Dulbecco’s modified Eagle medium
(DMEM) supplement with 10% fetal bovine serum
(FBS), 100 U/ml penicillin and 100 μg/ml streptomycin
(Life Technologies, Cergy Pontoise, France) in a humidi-
fied atmosphere of 5% CO2 at 37°C.
Chemicals and antibodies
LY294002 and PD98059 were purchased from Beyotime
(Jiangsu, China). Antibodies with specificity for the phos-
phorylated forms of Akt and ERK1/2 were purchased from
Cell signaling (Beverly, CA, USA). Antibodies recognizing
E-cadherin, N-cadherin, vimentin, snail and α-SMA were
bought from Abcam (Cambridge, TX, USA). Antibodies
recognizing β-actin, MMP-2 and MMP-9 antibodies were
obtained from Santa Cruz (Dallas, TX, USA).
Heat treatment
Insufficient RFA was simulated in vitro as described be-
fore [8]. Briefly, SMMC7721 or Huh7 cells were seeded
into the 6-well plates (5 × 104 cells/well). After 24 h, the
plates were sealed and submerged in a water bath set to
47°C for 5 min. Thereafter, cells were allowed to recover,
and when the surviving populations reached 80% conflu-
ence, cells were propagated into the 6-well plates and
exposed to above heat treatment for 10 min. Then the
process was repeated and cells were sequentially exposed
to above heat treatment for 15 min, 20 min and 25 min.
Cells survived from the treatment were designated as
SMMC7721-H and Huh7-H respectively. The morpho-
logical characteristics of HCC cells were observed by
microscopy (Olympus, Tokyo, Japan).
Proliferation assay
Cell proliferation was analyzed using the 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
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plates at a concentration of 3 × 103 cells/well, and incu-
bated for 24 h, 48 h, or 72 h. MTT solution was added
to each well at a final concentration of 0.5 mg/ml and
incubated for 4 h. At the end of incubation, formazan
crystals resulting from MTT reduction were dissolved by
addition of 150 μl dimethyl sulfoxide per well. The ab-
sorbance was measured at 570 nm using an automated
ELISA plate reader.
Colony formation assay
HCC cells were seeded into 6-well dishes at a concen-
tration of 1 × 103 cells/well and allowed to grow in
complete medium for 2 weeks. The colonies obtained
were washed with PBS and fixed in 4% paraformalde-
hyde for 20 min at room temperature and then washed
with PBS followed by staining with crystal violet. The
colonies were counted and compared with untreated
cells.
Migration and invasion assay
Quantitative cell migration assays were performed using
a modified Boyden chamber (Costar-Corning, New York,
USA) with 8.0-μm pore polycarbonate filter inserts in
24-well plates as described previously. Briefly, the lower
chamber was filled with DMEM with 10% FBS, and
HCC cells (5 × 104 cells/well) in serum-free medium
were added into the upper chamber. The cells were
allowed to migrate for 24 h at 37°C. The non-migrated
cells were removed from the upper surface of the mem-
brane by scraping with a cotton swab, and the migrating
cells were fixed with methanol, stained with crystal violet
(Beyotime, Nantong, China) and photographed under an
inverted fluorescence microscope (Olympus IX51) equip-
ped with an Olympus Qcolor 3 digital camera (Olympus).
Migration was assessed by counting the number of stained
cells from 10 random fields at × 200 magnification. Cell
invasion assay was performed similarly, except that trans-
well inserts were matrigel-coated.
Western blot
HCC cells were lysed with lysis buffer [150 mM NaCl,
50 mM Tris–HCl (pH 8.0), 0.1% SDS, 1% Triton X-100]
containing protease and phosphatase inhibitor (1 mM
Phenylmethanesulfonyl fluoride and 1 mM Sodium ortho-
vanadate). Cell lysate protein content was determined
using a Bicinchoninic acid (BCA) protein assay kit. Equi-
valent amounts of whole cell extracts were subjected to
SDS-PAGE and transferred to nitrocellulose membranes.
The membranes were blocked with 5% non-fat milk for
2 h and then incubated with respective primary antibody
overnight at 4°C followed by the incubation with the
appropriate HRP-conjugated secondary antibody for 1.5 h
at room temperature. Blots were visualized with an ECLdetection kit (Pierce, USA) and analyzed using Quantity
One 1-D Analysis Software (Bio-Rad, Hercules, USA).
Inhibitors
LY294002 or PD98059 was used to inhibit the expression
of p-Akt or p-ERK1/2 in HCC cells. Briefly, LY294002 or
PD98059 was added to the culture media of HCC cells at
a final concentration of 25 μM or 50 μM, after 24 h, cell
lysate protein was collected, and western blot was con-
ducted. In the migration and invasion assays, LY294002
(25 μM) or PD98059 (25 μM) was added to the upper
chamber, and after 24 h the chambers were collected.
Animals
Male BALB/c nu/nu mice (4–6 weeks old) were ob-
tained from Vital River Laboratories (Beijing, China) and
maintained under standard pathogen-free conditions.
The animal welfare guidelines for the care and use of
laboratory animals were approved by the Animal Care
Committee of Capital Medical University (Beijing, China).
Xenograft assays
SMMC7721 cells (5 × 106 cells) were suspended in
200 μl serum-free DMEM and matrigel (1:1) and then
injected subcutaneously into the upper right flank region
of 12 nude mice. Tumor size was measured with a cali-
per rule every 3 days. The tumor volume was estimated
with the formula “a × b2 × 0.5”, in which a represented
the longest and b the shortest radius of the tumor in
millimeters. At the end of the experiments, mice were
euthanized, blood samples were collected via cardiac
puncture, and tumor tissues were removed for fixation
in the 4% paraformaldehyde for histologic examination
and immunohistochemical staining.
Tail vein metastatic assays
HCC cells (1 × 106 cells) were suspended in 100 μl PBS
and injected through tail vein. Four weeks after the in-
jection, the mice were sacrificed and the lung tissues
were isolated. After counting the number of visible tu-
mors on lung surface, the lung tissues were made into
serial sections before HE staining and observed under a
light microscope.
Immunocytochemistry
Tissues were fixed in 4% paraformaldehyde and subse-
quently embedded in paraffin. Paraffin-embedded tissue
sections were cut into standard 6 μm sections, deparaffi-
naged in xylene and rehydrated through graded alcohol
solutions. Antigen retrieval was performed 10 min at 92°C
in EDTA (10 mM, pH 8.0) in a water bath. Endogenous
peroxidases were inactivated by immersing the sections in
0.3% hydrogen peroxide for 12 min. The sections were
blocked with 5% goat serum for 60 min at 37°C. The slides
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at 4°C. Next, the slides were treated with appropriate
HRP-conjugated secondary antibodies for 40 min at
37°C and then developed with 3,3’-diaminobenzidine.
Finally, the slides were counterstained with hematoxylin
and mounted. The slides were examined with Nikon
Eclipse Ti microscope under a × 200 objective.
Statistical analysis
All values are expressed as the mean ± SEM. The data
were analyzed using Student’s t test or the ANOVA test.
A P value of <0.05 was considered statistically signi-
ficant. GraphPad Prism (GraphPad Software Inc., San
Diego, California, USA) was used for these analyses.
Results
Insufficient RFA promoted HCC cells proliferation,
migration and invasion
To evaluate the effect of insufficient RFA on HCC cells,
SMMC7721 and Huh7 cells were treated with heat treat-
ment (47°C in a water bath) for 5 min, 10 min, 15 min,
20 min and 25 min gradually as described previously [8].
Three independent SMMC7721-H or Huh7-H cell lines
have ever been developed, and biological behavior of
each SMMC7721-H or Huh7-H cell line was similar.
The results of one of each were shown. SMMC7721-H
exhibited higher proliferation rate compared with
SMMC-7721 at 24 h, 48 h, and 72 h (7.6%, 9.9% and
6.4% increase respectively) (Figure 1A). To determine
the long term growth ability, HCC cells were allowed to
grow for 2 weeks. SMMC7721-H cells had a higher
number of colonies in comparing with SMMC7721 cells
(Figure 1B). SMMC7721-H cells also displayed enhanced
migration and invasion abilities (33.2% and 44.1%
increase respectively) compared with SMMC7721 cells
(Figure 1C). Similar patterns of cell proliferation, migra-
tion and invasion were also found in Huh7-H and Huh7
cells (Figure 1).
Insufficient RFA promoted EMT of HCC cells
Interestingly, we found that SMMC7721-H and Huh7-H
displayed a spindle shape with less cell-cell adhesion and
increased formation of pseudopodia (Figure 2A). To
evaluate whether EMT had occurred in SMMC7721-H
and Huh7-H cells, EMT markers were examined. Western
blot showed significant reduction in E-cadherin expres-
sion and up-regulation of N-cadherin, vimentin, α-SMA,
fibronectin, MMP-2 and MMP-9 (Figure 2B).
Insufficient RFA promoted EMT of HCC cells through Akt
and ERK1/2 signaling pathways
To explore the signaling mechanisms involved in the
EMT of HCC cells after insufficient RFA, we tested Akt
and ERK1/2 signaling pathways. SMMC7721-H showedsignificantly increased expression of p-Akt and p-ERK1/
2 compared with SMMC7721 (Figure 3A). Furthermore,
an up-regulation of the transcription factor snail was
also detected in SMMC7721-H (Figure 3A). PI3K/Akt
inhibitor LY294002, or ERK1/2 inhibitor PD98059
significantly suppressed the expression of p-Akt or p-
ERK1/2 in SMMC7721 and SMMC7721-H cells res-
pectively, also inhibited the expression of N-cadherin
and snail, and increased the expression of E-cadherin
(Figure 3B). LY294002 or PD98059 also suppressed the
migratory and invasive ability of SMMC7721 and
SMMC7721-H (Figure 3C and D). The significant differ-
ence of migratory and invasive ability of SMMC7721
and SMMC7721-H cells was also eliminated after
LY294002 or PD98059 was used (Figure 3C and D).
Similar results were also found in Huh7 and Huh7-H
cells (Additional file 1).
Insufficient RFA enhanced the growth of HCC cells in vivo
To examine the effects of insufficient RFA on tumor
growth in vivo, we evaluated the effect in a SMMC7721
ectopic HCC model. SMMC7721-H cells showed
increased tumor volume compared with SMMC7721
cells (1440.8 ± 250.3 mm3 versus 1048.56 ± 227.6 mm3)
(Figure 4A). Significant increases of cell proliferation
were observed by PCNA in SMMC7721-H tumors. In
addition, SMMC7721-H tumors showed decreased expres-
sion of E-cadherin and increased expression of N-cadherin,
MMP-2 and MMP-9 compared with SMMC7721 tumors
(Figure 4B). However, there were no apparent changes in
body weight in the mice (Additional file 2A).
HCC cells exhibited enhanced metastatic ability in vivo
after insufficient RFA
To determine the effects of insufficient RFA on the
in vivo metastasis of SMMC7721 cells, a tail vein metas-
tasis assay was used. The extent of the metastatic tumors
on the surface of the lung was significantly increased
(97.4% increase) in mice receiving SMMC7721-H cells
compared with SMMC7721 cells (Figure 5A). The lung
tissues were sectioned serially and HE staining also con-
firmed the results above (Figure 5B and C). However,
there were no apparent changes in body weight in the
mice (Additional file 2B).
Discussion
RFA is safe and more effective than resection for very early
HCC and in the presence of two or three nodules <3 cm,
however, its ability to obtain complete and sustained
tumor necrosis is less predictable [16]. So to further eluci-
date the biological behavior of residual HCC, involved
mechanisms after insufficient RFA is important to im-
prove prognosis of HCC patients. In the present study, we
demonstrated that insufficient RFA promoted the growth,
Figure 1 Insufficient RFA promoted the proliferation, colony formation, migration and invasion of HCC cells. SMMC7721 and Huh7 cells
were treated with insufficient RFA (47°C 5 min, 10 min, 15 min, 20 min and 25 min) gradually. Residual SMMC7721 and Huh7 (named as
SMMC7721-H and Huh7-H respectively) cells were collected and used for the next experiments. (A) Proliferation rate of SMMC7721, SMMC7721-H,
Huh7 and Huh7-H was evaluated by MTT assay. Error bars represent the SEM of data obtained in five independent experiments. (B) Colony
formation abilities of SMMC7721, SMMC7721-H, Huh7 and Huh7-H cells were assessed. Error bars represent the SEM of data obtained in three
independent experiments. (C) Migration and invasion of SMMC7721, SMMC7721-H, Huh7 and Huh7-H cells were shown. Error bars represent the
SEM of data obtained in three independent experiments. P value <0.05 was considered statistically significant; ***p < 0.001, **p < 0.01.
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more, enhanced migration and invasion of HCC cells after
insufficient RFA were associated with EMT. In addition,
rapid growth and enhanced metastasis of HCC cells after
insufficient RFA in vivo further confirmed the results
in vitro. Our results have demonstrated that EMT plays an
important role in enhancing invasiveness and metastasis
of HCC cells after insufficient RFA.
Our previous study elucidated that one sub-line
selected from HepG2 cells after insufficient RFA (47°C10 min) exhibited more rapid proliferation rate [8].
Although in the present study SMMC7721 and Huh7
cells were treated with insufficient RFA gradually (47°C
5 min, 10 min, 15 min, 20 min, and 25 min), the surviv-
ing SMMC7721-H and Huh7-H cells also showed higher
proliferation rate compared with SMMC7721 and Huh7
cells respectively. Interestingly, in the present study,
SMMC7721 and Huh7 cells after insufficient RFA dis-
played a spindle shape with less cell-cell adhesion and
increased formation of pseudopodia. So we inferred that
Figure 2 Insufficient RFA induced EMT in HCC cells. (A) The morphological changes of SMMC7721 and Huh7 cells after insufficient RFA were
displayed. (B) Cell extracts were subjected to western blot analysis and expression of E-cadherin, N-cadherin, fibronectin, vimentin, α-SMA, MMP-2
and MMP-9 were detected. Actin served as loading control.
Figure 3 Insufficient RFA promoted EMT of SMMC7721 cells through Akt and ERK1/2 signaling pathways. (A) The expression of p-Akt,
Akt, p-ERK1/2, ERK2 and snail in SMMC7721 and SMMC7721-H cells were assessed by western blot. (B) LY294002 or PD98059 was used to treat
HCC cells, and western blot was used to determined the expression of p-Akt, Akt, p-ERK1/2, ERK2, E-cadherin, N-cadherin, and snail. (C-D)
LY294002 or PD98059 was used to treat SMMC7721 and SMMC7721-H cells, and migration (C) and invasion (D) of SMMC7721 and SMMC7721-H
were evaluated. Error bars represent the SEM of data obtained in three independent experiments. P value <0.05 was considered statistically
significant; ***p < 0.001, **p < 0.01, ns, no significance.
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Figure 4 Insufficient RFA promoted the growth of HCC cells in vivo. SMMC7721 and SMMC7721-H cells were injected subcutaneously into
the upper right flank region of nude mice and tumor volume was measured. (A) Tumor volume was measured with a caliper rule every 3 days.
Data were presented as the mean tumor volumes of mice. Representative images of tumor volume were also exhibited. (B) Tumor sections were
stained with PCNA, MMP-2, MMP-9, E-cadherin and N-cadherin. Representive images of the immunohistochemistry assay were shown (× 200).
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of HCC cells. However, the mechanisms involved in the
process have not been elucidated and need to be studied
in the further.
Metastasis is a multistage process that requires cancer
cells to escape from the primary tumor, survive in the
circulation, seed at distant sites and grow [17]. Metasta-
sis has also always been a bottleneck in tumor prognosis
and therapy [18]. Metastasis, both intrahepatic and
extrahepatic, is of particular concern and occurs in more
than half of HCC cases [19]. Our previous study
suggested that tumor-associated endothelial cells after
insufficient RFA could promote invasiveness of residual
HCC cells in vitro [7]. Whether insufficient RFA could
enhance invasive potential of HCC cells has not been
determined. In this study, we found that SMMC7721
and Huh7 cells after insufficient RFA also exhibited
enhanced migration and invasive potential. The EMT
appears to be essential for cancerous cells to acquire the
capability of migration and invasion and is a key driver
to tumor cell translocation [20]. EMT is also a process
whereby cells change from cobble-stone shapes that ex-
hibit tight cell-cell contact into spindle-shape fibroblast-
like shapes that lose cell-cell contact and cell polarity[21-23]. The morphological changes of SMMC7721-H
and Huh7-H cells were consistent with the characteristics
of EMT. Down-regulation of E-cadherin and up-regula-
tion of N-cadherin, vimentin, α-SMA, and fibronectin
further confirmed that EMT occurred in HCC cells after
insufficient RFA. Recently, Yoshida S et al. also demon-
strated that sub-lethal heat treatment promoted EMT and
enhanced the malignant potential of HCC, which was
partly consistent with our results [24]. The tail vein metas-
tasis assay also showed that HCC cells after insufficient
RFA exhibited enhanced pulmonary metastasis ability,
which may further support our results in vivo. The results
also showed that HCC cells after insufficient RFA had
enhanced abilities of surviving in the circulation, colo-
nization and outgrowth within a secondary organ, in
which mesenchymal to epithelial transition (MET) plays a
key role [25]. The complex mechanisms involved in the
metastasis of HCC cells after insufficient RFA still need to
be determined. Furthermore, we examined the growth of
HCC cells after insufficient RFA in vivo. The expression of
PCNA and N-cadherin was higher and the expression of
E-cadherin was lower in SMMC7721-H cells than
SMMC7721 cells, which was consistent with the results
in vitro.
Figure 5 HCC cells after insufficient RFA exhibited enhanced metastatic ability in vivo. SMMC7721 and SMMC7721-H cells were injected
through tail vein of mice. (A) Lung metastasis was assessed. (B) The lung tissues were sectioned serially and stained with HE. Representative im-
ages of HE were shown (× 200). (C) The numbers of metastatic tumors were counted. Error bars represent the SEM of data obtained in three in-
dependent experiments. P value <0.05 was considered statistically significant; ***p < 0.001.
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migration in both the lung A549, and breast MDA-MB-
468 human adenocarcinoma cell lines, with A549 cells
also undergoing a partial EMT [26]. The heat stress used
in their study was 42°C 30 min, and the temperature
was 47°C 5 min, 10 min, 15 min, 20 min and 25 min in
our study, however, the results was partly consistent.
Although Lang BJ et al. demonstrated that heat stress
promoted cell migration independent of heat shock
factor 1, the mechanisms involved in the process had
not been further determined. Recently, Akt and ERK sig-
naling pathways have been reported to play a key role in
the EMT of cancers. Hepatitis B virus X protein re-
pressed miRNA-148a to enhance tumorigenesis through
Akt and ERK mediating EMT of HCC [27]. ERK/Akt
also regulated EZH2 and E-cadherin to influence theEMT of cancer [28]. TMPRSS4 and TAAC3 promoted
EMT through the activation of PI3K/Akt and ERK
signaling pathways [29,30]. Akt and ERK signaling
pathways also mediated HGF [31,32], TGF-β [33,34],
and EGFR [35,36] inducing EMT. In our study, HCC
cells after insufficient RFA exhibited higher expression
of p-Akt and p-ERK1/2, and PI3K inhibitor, LY294002,
and ERK inhibitor, PD98059, significantly inhibited the
expression of p-Akt and p-ERK1/2 respectively. LY294002
and PD98059 suppressed the migratory and invasive
abilities of SMMC7721-H and Huh7-H cells, and also
inhibited the higher expression of N-cadherin, fibronectin,
vimentin, α-SMA and snail in SMMC7721-H and Huh7-
H cells. Our results suggested that insufficient RFA may
induce the EMT of HCC cells through Akt and ERK
signaling pathways.
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Our results suggest that insufficient RFA could directly
promote the invasiveness and metastasis of HCC cells.
Insufficient RFA may promote the EMT of HCC cells
through Akt and ERK signaling pathways.
Additional files
Additional file 1: Insufficient RFA promoted EMT of Huh7 cells
through Akt and ERK1/2 signaling pathways. (A) The expression of
p-Akt, Akt, p-ERK1/2, ERK2 and snail in Huh7 and Huh7-H cells were
assessed by western blot. (B) LY294002 or PD98059 was used to treat
HCC cells, and western blot was used to determine the expression of
p-Akt, Akt, p-ERK1/2, ERK2, E-cadherin, N-cadherin, and snail. (C-D)
LY294002 or PD98059 was used to treat Huh7 and Huh7-H cells, and
migration (C) and invasion (D) of Huh7 and Huh7-H were evaluated. Error
bars represent the SEM of data obtained in three independent experi-
ments. P value <0.05 was considered statistically significant; ***p < 0.001,
**p < 0.01, ns, no significance.
Additional file 2: Curves of mice body weight in the xenograft
assays and tail vein metastatic assays. Mice body weight in the
xenograft assays (A) and tain vein metastatic assays (B) were shown.
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